ZURICH Nov 30 The Swiss blue-chip SMI
was seen opening 0.1 percent lower at 7,838 points on Wednesday,
according to premarket indications by bank Julius Baer
The following are some of the main factors expected to
affect Swiss stocks.
U.S. healthcare company Johnson & Johnson has raised
its offer for Actelion, a source told Reuters on Tuesday,
stepping up pressure on the Swiss biotech firm to accept a
Switzerland's largest cantonal bank on Wednesday said it
would be closing a total of 14 sites--8 of its own retail
locations and 6 operated by partners--over the next two years
due to a decline in over-the-counter business. Over-the-counter
transactions had declined nearly 40 percent over the past five
years, ZKB said, with around 90 percent of cash transactions
currently occurring via ATMs. Affected employees would all
receive other internal offers.
OERLIKON and SCHMOLZ & BICKENBACH
Hans Ziegler will be resigning with immediate effect from
the board of directors of both Oerlikon and Schmolz &
Bickenbach, both companies said, due to ongoing investigations
related to his person. Both companies are controlled by
billionaire Viktor Vekselberg's investment vehicle Renova.
* Oerlikon has acquired citim, a company
specialising in 3-D printed metal parts, for an undisclosed
price. Citim generated 12 million francs in sales in 2015,
Oerlikon said, and profitability in line with Oerlikon's surface
* Eastern Property Holding saw rental income rise to
$53.68 million in the first nine months of 2016 compared to
$52.81 million through September 2015.
* A municipal assembly agreed to Zug Estate Holding's
modified development plans for its Langweid/Suurstoffi
West site. A governing council must now still approve the plans,
with authorisation expected in the first half of 2017.
UBS consumption indicator due at 0700 GMT
Economic think-tank KOF due to release leading growth
indicator at 0800 GMT
(Reporting by Zurich newsroom)